BioSpace News Archive

BioForest

Silverback Therapeutics Raises $85 Million in Series C Financing; Company Announces Executive Promotions

Silverback Therapeutics, Inc. (“Silverback”) (“the Company”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform

September 23, 2020
·
4 min read
Uterine Fibroid Embolization Devices Market: Greater Awareness among Patients will Create New Growth Opportunities

Uterine fibroid embolization is a minimally invasive treatment used to treat fibroid tumors in the uterus.

September 23, 2020
·
5 min read
Pharmerging Market: Pharmaceutical Products to Witness Strong Growth in Near Future

The global pharmerging market is experiencing a significant rise, especially in the emerging economies across the world.

September 23, 2020
·
4 min read
Oncology Devices Market: Endoscopic devices segment is projected to account for a major share of the market

Oncology is a branch of science that investigates cancer cells. The oncology devices market comprises medical devices that help in the diagnosing and treating of cancer diseases.

September 23, 2020
·
5 min read
Drug Development

American CryoStem Announces: FDA has cleared its Investigational New Drug (IND) for Post-Concussion Syndrome for Phase I Clinical Trial

American CryoStem Corporation is a clinical stage biotechnology company, global licensor, and a pioneer in autologous cellular therapy processing.

September 23, 2020
·
7 min read
BioCapital

MacroGenics Announces MGC018 Publication in Molecular Cancer Therapeutics

Phase 1 dose expansion trial evaluating MGC018 in patients with mCRPC, TNBC and NSCLC is currently recruiting patients

September 23, 2020
·
5 min read